nach oben

Indian Journal of Surgical Oncology

Erschienen in:

03.09.2018 | Review Article

Prevalence and Impact of Human Papillomavirus on Head and Neck Cancers: Review of Indian Studies

verfasst von: Deepa Nair, Manish Mair, Arjun Singh, Anil D’Cruz

Erschienen in: Indian Journal of Surgical Oncology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Human papillomavirus (HPV) is an important emerging etiology for head and neck cancers (HNCs) worldwide. Considering its impact on prognosis, it is important to understand the true prevalence of HPV-associated HNCs in India. This article reviews the prevalence of HPV-related HNCs across various studies in India where the population is predominantly tobacco users, and studies its outcomes with respect to HPV.

IARC Monographs- Monographs available in PDF format. http://monographs.iarc.fr/ENG/Monographs/vol90/index.php. Accessed 27 Feb 2018

Combes J-D, Franceschi S (2014) Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral Oncol 50:370–379. https://doi.org/10.1016/j.oraloncology.2013.11.004 CrossRefPubMed

Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol Off J Am Soc Clin Oncol 29:4294–4301. https://doi.org/10.1200/JCO.2011.36.4596 CrossRef

Mehanna H, Beech T, Nicholson T, el-Hariry I, McConkey C, Paleri V, Roberts S (2013) Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region. Head Neck 35:747–755. https://doi.org/10.1002/hed.22015 CrossRefPubMed

Bharti AH, Chotaliya K, Marfatia YS (2013) An update on oral human papillomavirus infection. Indian J Sex Transm Dis 34:77–82. https://doi.org/10.4103/0253-7184.120533 CrossRef

Balaram P, Nalinakumari KR, Abraham E et al (1995) Human papillomaviruses in 91 oral cancers from Indian betel quid chewers--high prevalence and multiplicity of infections. Int J Cancer 61:450–454CrossRef

D’Costa J, Saranath D, Dedhia P et al (1998) Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 34:413–420CrossRef

Jacob SE, Sreevidya S, Chacko E, Pillai MR (2002) Cellular manifestations of human papillomavirus infection in laryngeal tissues. J Surg Oncol 79:142–150CrossRef

Nagpal JK, Patnaik S, Das BR (2002) Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 97:649–653CrossRef

10.

Koppikar P, deVilliers EM, Mulherkar R (2005) Identification of human papillomaviruses in tumors of the oral cavity in an Indian community. Int J Cancer 113:946–950CrossRef

11.

Mitra S, Banerjee S, Misra C et al (2007) Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population. J Clin Pathol 60(9):1040–1047. https://doi.org/10.1136/jcp.2005.034835. CrossRefPubMed

12.

Ghosh S, Ghosh A, Maiti GP, Alam N, Roy A, Roy B, Roychoudhury S, Panda CK (2008) Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: Correlation with progression and prognosis. Int J Cancer 123(11):2594–2604. https://doi.org/10.1002/ijc.23834 CrossRefPubMed

13.

Gheit T, Vaccarella S, Schmitt M, Pawlita M, Franceschi S, Sankaranarayanan R, Sylla BS, Tommasino M, Gangane N (2009) Prevalence of human papillomavirus types in cervical and oral cancers in Central India. Vaccine 27:636–639. https://doi.org/10.1016/j.vaccine.2008.11.041 CrossRefPubMed

14.

Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Singh M, Singh M (2010) Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma. Virol J 7:253. https://doi.org/10.1186/1743-422X-7-253 CrossRefPubMedPubMedCentral

15.

Jalouli J, Ibrahim SO, Mehrotra R, Jalouli MM, Sapkota D, Larsson PA, Hirsch JM (2010) Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India. Acta Otolaryngol 130(11):1306–1311. https://doi.org/10.3109/00016481003782041 CrossRefPubMed

16.

Barwad A, Sood S, Gupta N, Rajwanshi A, Panda N, Srinivasan R (2012) Human papilloma virus associated head and neck cancer: A PCR based study. Diagn Cytopathol 40(10):893–897. https://doi.org/10.1002/dc.21667 CrossRefPubMed

17.

Kulkarni SS, Kulkarni SS, Vastrad PP, Kulkarni BB, Markande AR, Kadakol GS, Hiremath SV, Kaliwal S, Patil BR, Gai PB (2011) Prevalence and distribution of high risk human papillomavirus (HPV) Types 16 and 18 in Carcinoma of cervix, saliva of patients with oral squamous cell carcinoma and in the general population in Karnataka, India. Asian Pac J Cancer Prev 12(3):645–648PubMed

18.

Mondal R, Ghosh SK, Choudhury JH, Seram A, Sinha K, Hussain M, Laskar RS, Rabha B, Dey P, Ganguli S, Nathchoudhury M, Talukdar FR, Chaudhuri B, Dhar B (2013) Mitochondrial DNA copy number and risk of oral cancer: a report from Northeast India. PLoS One 8(3):e57771. https://doi.org/10.1371/journal.pone.0057771 CrossRefPubMedPubMedCentral

19.

Bahl A, Kumar P, Dar L, Mohanti BK, Sharma A, Thakar A, Karthikeyan V, Sikka K, Singh C, Poo K, Lodha J (2014) Prevalence and trends of human papillomavirus in oropharyngeal cancer in a predominantly north Indian population. Head Neck 36(4):505–510. https://doi.org/10.1002/hed.23317 CrossRefPubMed

20.

Ramshankar V, Soundara VT, Shyamsundar V, Ramani P, Krishnamurthy A (2014) Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. Asian Pac J Cancer Prev APJCP 15:8351–8359CrossRef

21.

Singh V, Husain N, Akhtar N, Kumar V, Tewari S, Mishra S, Misra S, Khan MY (2015) Do Human Papilloma Viruses Play Any Role in Oral Squamous Cell Carcinoma in North Indians? Asian Pac J Cancer Prev 16(16):7077–7084CrossRef

22.

Kumar R, Rai AK, Das D, Das R, Kumar RS, Sarma A, Sharma S, Kataki AC, Ramteke A (2015) Alcohol and tobacco increases risk of high risk HPV infection in head and neck cancer patients: study from north-east region of India. PLoS One 10:e0140700. https://doi.org/10.1371/journal.pone.0140700 CrossRefPubMedPubMedCentral

23.

Jitani AK, Raphael V, Mishra J et al (2015) Analysis of human papilloma virus 16/18 DNA and its correlation with p16 expression in oral cavity squamous cell carcinoma in North-Eastern India: a chromogenic in-situ hybridization based study. J Clin Diagn Res 9:EC04-07. https://doi.org/10.7860/JCDR/2015/13022.6285 CrossRef

24.

Parshad S, Nandi S, Marwah N et al (2015) Human papillomavirus 16 and 18 in squamous cell carcinoma of oral cavity and sexual practices: A pilot study at a Tertiary Care Hospital of North India. Natl J Maxillofac Surg 6(2):185–189. https://doi.org/10.4103/0975-5950.183857 CrossRefPubMedPubMedCentral

25.

Ralli M, Singh S, Yadav SPS, Sharma N, Verma R, Sen R (2016) Assessment and clinicopathological correlation of p16 expression in head and neck squamous cell carcinoma. J Cancer Res Ther 12:232–237. https://doi.org/10.4103/0973-1482.151447 CrossRefPubMed

26.

Singh AK, Kushwaha JK, Anand A, Sonkar AA, Husain N, Srivastava K, Singh S (2016) Human papilloma virus in oral cavity cancer and relation to change in quality of life following treatment-a pilot study from northern India. Indian J Surg Oncol 7:386–391. https://doi.org/10.1007/s13193-016-0559-4 CrossRefPubMedPubMedCentral

27.

Murthy V, Swain M, Teni T, Pawar S, Kalkar P, Patil A, Chande A, Ghonge S, Laskar SG, Gupta T, Budrukkar A, Agrawal J (2016) Human papillomavirus/p16 positive head and neck cancer in India: prevalence, clinical impact, and influence of tobacco use. Indian J Cancer 53:387–393. https://doi.org/10.4103/0019-509X.200668 CrossRefPubMed

28.

Verma G, Vishnoi K, Tyagi A et al (2017) Characterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers. Cancer Med 6(3):591–604. https://doi.org/10.1002/cam4.983 CrossRefPubMedPubMedCentral

29.

Gheit T, Anantharaman D, Holzinger D, Alemany L, Tous S, Lucas E, Prabhu PR, Pawlita M, Ridder R, Rehm S, Bogers J, Maffini F, Chiocca S, Lloveras B, Kumar RV, Somanathan T, de Sanjosé S, Castellsagué X, Arbyn M, Brennan P, Sankaranarayanan R, Pillai MR, Gangane N, Tommasino M, HPV-AHEAD study group (2017) Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India. Int J Cancer 141(1):143–151. https://doi.org/10.1002/ijc.30712. CrossRefPubMed

30.

Yete S, D’Souza W, Saranath D (2017) High-risk human papillomavirus in oral cancer: clinical implications. Oncology 94:133–141. https://doi.org/10.1159/000485322 CrossRefPubMed

31.

Elango KJ, Suresh A, Erode EM, Subhadradevi L, Ravindran HK, Iyer SK, Iyer SK, Kuriakose MA (2011) Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev APJCP 12:889–896PubMed

32.

Sannigrahi MK, Singh V, Sharma R, Panda NK, Radotra BD, Khullar M (2016) Detection of active human papilloma virus-16 in head and neck cancers of Asian North Indian patients. Oral Dis 22:62–68. https://doi.org/10.1111/odi.12382 CrossRefPubMed

33.

Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, Spencer S, Harris J, Chung CH, Ang KK (2012) Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol Off J Am Soc Clin Oncol 30:2102–2111. https://doi.org/10.1200/JCO.2011.38.4099 CrossRef

34.

Herrero R, Castellsagué X, Pawlita M et al (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95:1772–1783CrossRef

35.

Würdemann N, Wagner S, Sharma SJ, Prigge ES, Reuschenbach M, Gattenlöhner S, Klussmann JP, Wittekindt C (2017) Prognostic impact of AJCC/UICC 8th edition new staging rules in oropharyngeal squamous cell carcinoma. Front Oncol 7. https://doi.org/10.3389/fonc.2017.00129

36.

Marur S, D’Souza G, Westra WH, Forastiere AA (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11:781–789. https://doi.org/10.1016/S1470-2045(10)70017-6 CrossRefPubMedPubMedCentral

37.

Ang KK, Sturgis EM (2012) Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol 22:128–142. https://doi.org/10.1016/j.semradonc.2011.12.004 CrossRefPubMed

38.

Gillison ML (2004) Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 31:744–754CrossRef

39.

O’Sullivan B, Huang SH, Su J et al (2016) Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 17:440–451. https://doi.org/10.1016/S1470-2045(15)00560-4 CrossRefPubMed

40.

Haughey BH, Sinha P, Kallogjeri D, Goldberg RL, Lewis JS Jr, Piccirillo JF, Jackson RS, Moore EJ, Brandwein-Gensler M, Magnuson SJ, Carroll WR, Jones TM, Wilkie MD, Lau A, Upile NS, Sheard J, Lancaster J, Tandon S, Robinson M, Husband D, Ganly I, Shah JP, Brizel DM, O’Sullivan B, Ridge JA, Lydiatt WM (2016) Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx. Oral Oncol 62:11–19. https://doi.org/10.1016/j.oraloncology.2016.09.004 CrossRefPubMedPubMedCentral

41.

Sharma A, Méndez E, Yueh B, Lohavanichbutr P, Houck J, Doody DR, Futran ND, Upton MP, Schwartz SM, Chen C (2012) Human papillomavirus-positive oral cavity and oropharyngeal cancer patients do not have better quality-of-life trajectories. Otolaryngol Head Neck Surg 146:739–745. https://doi.org/10.1177/0194599811434707 CrossRefPubMedPubMedCentral

42.

Spinato G, Stellin M, Azzarello G, Bonazza D, Zanconati F, Politi D, Cocuzza S, di Mauro P, Ausoni S, Tonoli G, Costantini G, Maiolino L, Spinato R, da Mosto MC, Baboci L, del Mistro A, Serra A, Tirelli G (2017) Multicenter research into the quality of life of patients with advanced oropharyngeal carcinoma with long-term survival associated with human papilloma virus. Oncol Lett 14:185–193. https://doi.org/10.3892/ol.2017.6152 CrossRefPubMedPubMedCentral

43.

Wirth LJ (2016) Cetuximab in human papillomavirus–positive oropharynx carcinoma. J Clin Oncol 34:1289–1291. https://doi.org/10.1200/JCO.2015.65.1414 CrossRefPubMed

44.

Marur S, Li S, Cmelak AJ, Gillison ML, Zhao WJ, Ferris RL, Westra WH, Gilbert J, Bauman JE, Wagner LI, Trevarthen DR, Balkrishna J, Murphy BA, Agrawal N, Colevas AD, Chung CH, Burtness B (2016) E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of the oropharynx— ECOG-ACRIN Cancer Research Group. J Clin Oncol 35:490–497. https://doi.org/10.1200/JCO.2016.68.3300 CrossRefPubMedPubMedCentral

45.

Mirghani H, Blanchard P (2018) Treatment de-escalation for HPV-driven oropharyngeal cancer: where do we stand? Clin Transl Radiat Oncol 8:4–11. https://doi.org/10.1016/j.ctro.2017.10.005 CrossRefPubMed

46.

Gillison ML, Chaturvedi AK, Lowy DR (2008) HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 113:3036–3046. https://doi.org/10.1002/cncr.23764 CrossRefPubMed

Titel: Prevalence and Impact of Human Papillomavirus on Head and Neck Cancers: Review of Indian Studies
verfasst von: Deepa Nair
Manish Mair
Arjun Singh
Anil D’Cruz
Publikationsdatum: 03.09.2018
Verlag: Springer India
Erschienen in: Indian Journal of Surgical Oncology / Ausgabe 4/2018
Print ISSN: 0975-7651
Elektronische ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-018-0813-z

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Occult Gallbladder Carcinoma Presenting as a Primary Ovarian Tumour: a Case Report and Review of Literature

Multiple Gastrointestinal Cancers in a Single Patient—a Rare Clinical Entity

Outcome of Bowel Resection in Women with Advanced Ovarian Carcinoma

Clinical Utility of Staging Laparoscopy for Advanced Obstructing Rectal Adenocarcinoma: Emerging Tool

Esophageal Metallic-Stent Migration: a Rare Cause of Anal Pain in a Patient with Gastric Cancer

Recurrent Retroperitoneal Liposarcoma: a Case Report and Literature Review

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“